Cytosorbents Corp — Director's Dealing 2013

Feb 22, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2013-02-06

Reporting Person: Kraus Al (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-06	Stock Option	$0.106	A	300000	Acquired	2023-02-06	Common Stock (300000)	Direct

Footnotes

F1: On January 6, 2013, Mr. Al Kraus was issued an option to purchase 300,000 shares of common stock at an exercise price of $0.106 per share which will expire on January 6, 2023. The options were issued pursuant to the terms of his re-appointment as a member of the Board of Directors.